1. Thailand Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
Thai Optical Group Public Company Limited

Thai Optical Group Public Company Limited

TOG.BK
Thai Optical Group Public Company LimitedTH flagStock Exchange of Thailand
7.60
THB
+0.15
- -
3.60BMarket Cap
Thai Optical Group Public Company Limited
TOG.BK
(Stock Exchange of Thailand)

Recent

price

7.60

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
3.08
2.41
3.04
3.45
3.86
3.85
4.08
3.96
3.94
4.22
3.87
5.02
6.16
6.31
7.33
7.46
7.47
Revenue per Share
0.3
-0.14
0.32
0.33
0.43
0.48
0.53
0.39
0.31
0.28
0.15
0.65
0.85
0.9
0.87
0.71
0.71
Basic EPS, GAAP
0.13
-0.11
-0.07
0.67
0.26
0.59
0.11
0.01
0.26
0.28
0.41
0.17
0.54
-0.89
0.29
0.52
0.74
Free Cash Flow per Basic Share
0.25
0.2
0.1
0.23
0.32
0.31
0.4
0.4
0.33
0.32
0.15
0.33
0.52
0.63
0.65
0.45
0.45
Dividend per Share
2.01
1.73
1.93
2.02
2.13
2.29
2.41
2.4
2.37
2.32
2.31
2.64
2.97
3.22
3.44
3.7
3.91
Book Value per Share
3.29
3.07
3.31
3.43
3.57
3.75
3.87
3.85
3.84
3.77
3.76
4.09
4.43
4.66
4.81
4.99
5.2
Tangible Book Value per Share
469
470
472
473
474
474
474
474
474
474
474
474
474
474
474
474
474
Basic Weighted Avg Shares
1,445
1,133
1,432
1,630
1,831
1,824
1,934
1,878
1,870
2,001
1,838
2,381
2,923
2,993
3,477
3,539
3,541
Sales/Revenue/Turnover
14.76
-4.03
5.72
9.97
12.89
12.96
12.98
11.84
6.39
6.53
3.2
12.26
14.23
16.34
14.55
11.71
11.16
Operating Margin (%)
102
124
145
159
157
147
148
154
191
189
188
184
179
165
221
286
289
Depreciation Expense
139
-66
153
154
203
230
250
183
146
132
69
310
404
426
412
334
339
Net Income, GAAP
29.87
- -
23.09
20.2
19.59
19.25
18.46
18.24
5.13
- -
- -
7.1
6.57
8.47
10.67
6.53
5.88
Effective Tax Rate (%)
9.63
-5.81
10.65
9.46
11.1
12.59
12.95
9.77
7.81
6.6
3.74
13.03
13.81
14.22
11.86
9.45
9.57
Profit Margin (%)
777
523
646
763
803
915
656
716
864
787
762
919
1,065
953
940
932
1,024
Working Capital
55
2
1
- -
- -
- -
11
63
148
85
64
21
12
363
526
472
441
LT Debt
1,631
1,513
1,617
1,665
1,718
1,799
1,856
1,848
1,837
1,808
1,807
1,957
2,115
2,238
2,339
2,460
2,563
Total Equity
8.84
- -
3.55
7.18
10.61
10.24
10.08
8.07
4.86
- -
- -
10.9
14.68
14.14
12.1
9.79
9.18
Return on Invested Capital (%)
14.06
- -
14.93
14.75
19.33
20.53
19.49
12.27
9.68
- -
- -
17.84
21.23
18.38
14.99
11.64
11.33
Return on Capital (%)
14.46
-7.51
17.68
16.52
20.7
21.92
22.44
16.09
12.91
11.88
6.27
26.44
30.35
28.98
26.1
19.77
18.89
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
1,026
1,056
1,025
LT Borrowings
481
449
417
LT Finance Leases
24
23
24
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
474
474
474
Market Capitalization
3,439
3,154
3,225

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
2,394
2,476
2,535
Cash, Cash Equivalents & STI
165
165
216
Accounts Receivable, Net
490
521
536
Inventories
1,596
1,665
1,709
Total Current Liabilities
1,558
1,544
1,511
Payables & Accruals
524
483
464
ST Debt
1,026
1,056
1,025
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
3.24%
6.38%
5.19%
Free Cash Flow
268.72%
-30.64%
81.22%
Net Income, GAAP
26.89%
72.89%
-18.87%
Sales/Revenue/Turnover
7.42%
14.54%
1.78%
Total Cash Common Dividend
- -
34.2%
-30.81%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
845
945
858
830
3,477
2025
899
871
838
930
3,539
2026
901
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.24
0.25
0.14
- -
0.87
2025
0.21
0.09
0.17
- -
0.71
2026
0.22
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.45
0.2
- -
0.65
2025
- -
0.25
0.2
- -
0.45
2026
- -
- -
- -
- -
- -
Similar Companies
Terumo Corporation (TRUMY)
Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS)
ConvaTec Group Plc (CTEC.L)
Elekta AB (publ) (EKTAF)
Bionime Corporation (4737.TW)
Dr. Agarwal's Health Care Limited (AGARWALEYE.NS)
Business
Thai Optical Group Public Company Limited is a prominent manufacturer and global supplier of ophthalmic lenses and associated optical items. The company operates through distinct divisions: the primary one dedicated to plastic and glass lenses, and another encompassing diverse products and services. Within its core lens segment, it engineers and markets a comprehensive array of vision correction solutions, including standard, value-added, and advanced prescription lenses for various needs, such as single vision and progressive designs, produced from both organic and mineral materials. The secondary segment encompasses the sale of glass molds, trading optical goods for resale, providing specialized surface treatments like hard and anti-reflection coatings for organic lenses, and offering glasses assembly services. With more than seventy years of operational history, this Thai-based enterprise distributes its diverse product lines, which include proprietary brands such as PROGRES HD, BLULOC, and ZAPHIRE, to wholesalers and retailers across more than fifty countries spanning six continents. Its international reach extends significantly to regions including Europe, Australia, the Asia Pacific, the Americas, Africa, and the Middle East, supported by distribution hubs in the United States and Europe. The company recently launched a Data & AI Transformation initiative and continues to strategically adapt to global economic conditions through market diversification and a focus on ESG principles for sustainable growth. Established in 1951, initially as Thai Polymer Lens Company Limited before adopting its current name in 2004, the firm maintains its headquarters in Nonthaburi, Thailand.